|
Clindamycin Phosphate In Dextrose 5% In Plastic ContainerDrug - Clindamycin Phosphate In Dextrose 5% In Plastic Container The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Clindamycin Phosphate
Strength -
EQ 18MG BASE/ML
Applicant -
ABBOTT
New Drug Application (NDA) Number -
065027
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
Jun 29, 2001
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Abbott Laboratories
Clindamycin Phosphate In Dextrose 5% In Plastic Container
Clindamycin Phosphate Eq 150mg Base/ml Injectable; Injection
Clindamycin Phosphate Eq 150mg Base/ml Injectable; Injection Clindamycin Phosphate Eq 150mg Base/ml Injectable; Injection Clindamycin Phosphate In Dextrose 5% Eq 12mg Base/ml Injectable; Injection Clindamycin Phosphate In Dextrose 5% Eq 900mg Base/100ml Injectable; Injection Clindamycin Phosphate In Dextrose 5% In Plastic Container Eq 12mg Base/ml Injectable; Injection Clindamycin Phosphate In Dextrose 5% In Plastic Container Eq 18mg Base/ml Injectable; Injection Clindamycin Phosphate Eq 150mg Base/ml Injectable; Injection Clindamycin Phosphate Eq 150mg Base/ml Injectable; Injection Clindamycin Phosphate Eq 150mg Base/ml Injectable; Injection NewDrugInformation |